First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group-Reference-Cited by-同舟云学术

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

Published:1998-09 Issue:9 Volume:9 Page:1031-1034
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Fountzilas G.,Dimopoulos A.-M.,Papadimitriou C.,Kalogera-Fountzila A.,Aravantinos G.,Bafaloukos D.,Athanassiades A.,Nicolaides C.,Keramopoulos A.,Pavlidis N.,Kosmidis P.,Skarlos D.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/9/9/1031/19481994/9-9-1031.pdf

Reference11 articles.

1. Drug therapy: Paclitaxel (Taxol);Rowinsky;N Engl J Med,1995

2. Biweekly paclitaxel in the treatment of patients with metastatic breast cancer;Gelmon;Semin Oncol,1995

3. Carboplatin in the treatment of advanced breast cancer: A phase II study using a pharmacokinetically guided dose schedule;O’Brien;J Clin Oncol,1993

4. Paclitaxel by three-hour infusion and carboplatin in anthracycline-resistant advanced breast cancer. A phase II study conducted by the Hellenic Cooperative Oncology Group;Fountzilas;Eur J Cancer,1997

5. Paclitaxel and carboplatin as first-line chemotherapy for advanced breast cancer;Fountzilas;Oncology,1998

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel, Carboplatin, and Trastuzumab;Hospital Pharmacy;2014-10-01

2. Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer;Chemotherapy;2011

3. A Phase II Trial of Oxaliplatin and Trastuzumab in the Treatment of HER2-Positive Metastatic Breast Cancer;Cancer Investigation;2010-08-06

4. Paclitaxel and Carboplatin as Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer: A Phase II Trial of the Hellenic Cooperative Oncology Group;Clinical Breast Cancer;2010-06

5. Fifteen-year trends in metastatic breast cancer survival in Greece;Breast Cancer Research and Treatment;2009-11-14